UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (122541) 122541
Newspaper Article (950) 950
Newsletter (631) 631
Book Chapter (269) 269
Magazine Article (116) 116
Government Document (108) 108
Book / eBook (41) 41
Publication (25) 25
Dissertation (22) 22
Conference Proceeding (16) 16
Web Resource (4) 4
Book Review (2) 2
Paper (2) 2
Journal / eJournal (1) 1
Trade Publication Article (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (106738) 106738
science & technology (86130) 86130
life sciences & biomedicine (80666) 80666
male (55065) 55065
female (52586) 52586
middle aged (44701) 44701
aged (38245) 38245
oncology (36196) 36196
adult (31294) 31294
animals (25921) 25921
cancer (20324) 20324
immunohistochemistry (19868) 19868
prognosis (18384) 18384
antigens (17509) 17509
mice (16993) 16993
tumors (15196) 15196
aged, 80 and over (15169) 15169
prostate cancer (13243) 13243
pathology (13055) 13055
abridged index medicus (12179) 12179
antigens, neoplasm - analysis (11689) 11689
research (11559) 11559
analysis (11290) 11290
cell line, tumor (10283) 10283
immunology (10018) 10018
neoplasm staging (9960) 9960
prostate-specific antigen - blood (9487) 9487
metastasis (9172) 9172
care and treatment (8948) 8948
biomarkers, tumor - analysis (8787) 8787
retrospective studies (8714) 8714
immunotherapy (8697) 8697
prostatic neoplasms - pathology (8626) 8626
gene expression (7864) 7864
research article (7849) 7849
surgery (7764) 7764
cell biology (7496) 7496
health aspects (7336) 7336
proteins (7229) 7229
urology & nephrology (7190) 7190
treatment outcome (7182) 7182
flow cytometry (6769) 6769
adolescent (6629) 6629
hematology (6515) 6515
risk factors (6477) 6477
antigens, neoplasm - immunology (6447) 6447
diagnosis (6363) 6363
patients (6332) 6332
carcinoembryonic antigen - analysis (6211) 6211
breast cancer (6176) 6176
apoptosis (6088) 6088
chemotherapy (5948) 5948
medicine (5897) 5897
medicine & public health (5743) 5743
prostatic neoplasms - blood (5669) 5669
follow-up studies (5665) 5665
tumor cells, cultured (5608) 5608
gene expression regulation, neoplastic (5602) 5602
biopsy (5564) 5564
genetic aspects (5521) 5521
prostate-specific antigen (5498) 5498
lymphocytes (5448) 5448
survival analysis (5438) 5438
science & technology - other topics (5404) 5404
cell proliferation (5393) 5393
medical prognosis (5367) 5367
biomarkers, tumor - blood (5356) 5356
biomarkers, tumor - metabolism (5156) 5156
medicine, research & experimental (5132) 5132
research & experimental medicine (5125) 5125
t cells (5054) 5054
multidisciplinary sciences (5042) 5042
cancer therapies (4936) 4936
prostatic neoplasms - diagnosis (4920) 4920
biochemistry & molecular biology (4917) 4917
cell line (4875) 4875
immunoenzyme techniques (4841) 4841
development and progression (4840) 4840
predictive value of tests (4822) 4822
biomarkers (4814) 4814
neoplasms - immunology (4809) 4809
sensitivity and specificity (4777) 4777
disease-free survival (4756) 4756
time factors (4738) 4738
breast neoplasms - pathology (4536) 4536
diagnosis, differential (4368) 4368
medical research (4337) 4337
studies (4335) 4335
child (4308) 4308
survival rate (4305) 4305
mutation (4254) 4254
t-lymphocytes - immunology (4198) 4198
multivariate analysis (4175) 4175
stem cells (4125) 4125
antibodies, monoclonal (4082) 4082
disease progression (4058) 4058
antigens, neoplasm - genetics (4052) 4052
adenocarcinoma - pathology (3992) 3992
neoplasm metastasis (3979) 3979
metastases (3875) 3875
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (20) 20
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Online Resources - Online (3) 3
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (119454) 119454
Japanese (2280) 2280
Chinese (1305) 1305
German (1155) 1155
French (951) 951
Russian (759) 759
Italian (455) 455
Spanish (448) 448
Portuguese (273) 273
Polish (249) 249
Czech (93) 93
Korean (47) 47
Hungarian (46) 46
Norwegian (40) 40
Croatian (35) 35
Romanian (28) 28
Danish (27) 27
Bulgarian (25) 25
Dutch (23) 23
Serbian (21) 21
Hebrew (19) 19
Slovak (19) 19
Turkish (13) 13
Swedish (12) 12
Ukrainian (9) 9
Finnish (7) 7
Arabic (4) 4
Lithuanian (2) 2
Bosnian (1) 1
Greek (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer immunology, immunotherapy, ISSN 1432-0851, 12/2006, Volume 56, Issue 8, pp. 1173 - 1182
.... Furthermore, multivariate analysis indicated that tumor-associated B7-H1 was more significant prognostic factor than WHO grade... 
Urothelial cancer | Biomedicine | Immunology | B7-H1/PD-L1 | Costimulation | T cell | Oncology | Cancer Research | Antitumor immunity | PD-1 | Life Sciences & Biomedicine | Science & Technology | Carcinoma, Transitional Cell - mortality | Prognosis | Antigens, CD - biosynthesis | Humans | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | Kidney Pelvis - chemistry | Ureteral Neoplasms - pathology | Male | Kidney Neoplasms - chemistry | Antigens, CD - genetics | Antigens, CD - analysis | Kidney Neoplasms - surgery | Urinary Bladder Neoplasms - pathology | Female | Neoplasm Proteins - genetics | Kidney Pelvis - surgery | Urinary Bladder Neoplasms - mortality | B7-H1 Antigen | Neoplasm Proteins - biosynthesis | Ureteral Neoplasms - chemistry | Neoplasm Recurrence, Local | Proportional Hazards Models | Kidney Pelvis - pathology | Immunophenotyping | Kidney Neoplasms - mortality | Urinary Bladder Neoplasms - surgery | Carcinoma, Transitional Cell - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Carcinoma, Transitional Cell - chemistry | Survival Analysis | Antigens, CD - physiology | Kidney Neoplasms - pathology | Neoplasm Proteins - analysis | Urinary Bladder Neoplasms - chemistry | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Lymphocytes, Tumor-Infiltrating - immunology | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
PloS one, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, pp. e0179501 - e0179501
Innovative therapies for solid tumors are urgently needed. Recently, therapies that harness the host immune system to fight cancer cells have successfully... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Colonic Neoplasms - genetics | DNA Methylation - immunology | DNA, Neoplasm - metabolism | Humans | Antigens, Neoplasm - biosynthesis | Ovarian Neoplasms - pathology | Male | Colonic Neoplasms - metabolism | Testicular Neoplasms - pathology | Ovarian Neoplasms - genetics | Colonic Neoplasms - immunology | Female | Ovarian Neoplasms - metabolism | Caco-2 Cells | Antigens, Neoplasm - genetics | Testicular Neoplasms - genetics | Antigens, Neoplasm - immunology | Testicular Neoplasms - metabolism | Antigen Presentation - genetics | DNA Methylation - genetics | Testicular Neoplasms - immunology | Animals | Colonic Neoplasms - pathology | DNA, Neoplasm - immunology | Mice | DNA, Neoplasm - genetics | Ovarian Neoplasms - immunology | Colon cancer | Tumor antigens | Physiological aspects | Development and progression | Genetic aspects | Research | Methylation | Ovarian cancer | Therapy | Biotechnology | Animal models | Ovarian carcinoma | Medical innovations | CD58 antigen | Antigen processing | Genomes | Tissues | Cancer therapies | Immunotherapy | Surgery | Cell cycle | DNA methylation | Inhibition | Colon | Drug dosages | Deoxyribonucleic acid--DNA | Immune system | Antigen presentation | Antigens | Tumor cells | Melanoma | Tumor cell lines | Gene expression | Ribonucleic acid--RNA | Patients | Medicine | Inhibitors | Epigenetics | Solid tumors | Tumors | Cancer | Index Medicus | RNA | Deoxyribonucleic acid | Ribonucleic acid | DNA
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, pp. e0130142 - e0130142
...). Interaction test according to tumor PD-L1 was accomplished. A sensitivity analysis according to adopted drug, tumor type, PD-L1 cut-off and treatment line was performed... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Lung Neoplasms - drug therapy | Melanoma - diagnosis | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Neoplasms - diagnosis | Urogenital System - pathology | Neoplasms - genetics | Melanoma - genetics | Urogenital Neoplasms - drug therapy | Lung - metabolism | Lung Neoplasms - genetics | Lung - pathology | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | Treatment Outcome | Urogenital System - drug effects | B7-H1 Antigen - genetics | Neoplasms - drug therapy | Urogenital System - metabolism | Urogenital Neoplasms - genetics | Lung - drug effects | Melanoma - drug therapy | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Urogenital Neoplasms - diagnosis | Lung cancer, Non-small cell | Care and treatment | Tumors | PD-1 protein | Lung cancer | Clinical trials | Antibodies | Oncology | Cancer therapies | Confidence intervals | Immunotherapy | Sensitivity analysis | Tumor cells | Melanoma | Non-small cell lung carcinoma | Patients | Pathology | Immune checkpoint | Medical prognosis | PD-L1 protein | Biomarkers | Ligands | Mutation | Solid tumors | Blood diseases | Cancer | Apoptosis | Index Medicus
Journal Article
Brain (London, England : 1878), ISSN 1460-2156, 04/2012, Volume 135, Issue 4, pp. 1042 - 1054
Peptides presented at the cell surface reflect the protein content of the cell; those on HLA class I molecules comprise the critical peptidome elements... 
peptidome | glioblastoma | tumour-infiltrating lymphocytes | tumour antigen | immunotherapy | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Oligonucleotide Array Sequence Analysis | Humans | Brain Neoplasms - pathology | Gene Expression Profiling | Glial Fibrillary Acidic Protein - metabolism | RNA, Messenger - metabolism | Antigens, Neoplasm - chemistry | HLA-A Antigens - analysis | Antigens, CD - metabolism | Sequence Analysis, Protein | Brain Neoplasms - immunology | Flow Cytometry | Antigens, Neoplasm - therapeutic use | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Mass Spectrometry | Chromatography, Liquid | Cytokines - metabolism | Antigens, Neoplasm - immunology | Peptides - immunology | Glioblastoma - therapy | HLA-A Antigens - immunology | Glioblastoma - immunology | Glioblastoma - pathology | Brain Neoplasms - therapy | HLA-A Antigens - chemistry | CD8-Positive T-Lymphocytes - immunology | Antigen Presentation - physiology | Peptides - analysis | Receptor-Like Protein Tyrosine Phosphatases, Class 5 - metabolism | Index Medicus | Abridged Index Medicus | Immunogenicity | CD8 antigen | Immunotherapy | Glioblastoma | Data processing | Histocompatibility antigen HLA | Lymphocytes T | Vaccines | Cell surface | Immunological tolerance
Journal Article
Cancer immunology, immunotherapy, ISSN 1432-0851, 11/2005, Volume 55, Issue 7, pp. 808 - 818
This study was designed to determine the characteristics of tumour cell-derived microvesicles (TMV) and their interactions with human monocytes. TMV were shed... 
Monocytes | Biomedicine | Immunology | Transfer | Oncology | Cancer Research | mRNA | CCR6 | Tumour-derived microvesicles | Life Sciences & Biomedicine | Science & Technology | RNA, Messenger - immunology | Adenocarcinoma - ultrastructure | Tetradecanoylphorbol Acetate - pharmacology | Humans | Neoplasm Proteins - immunology | RNA, Messenger - analysis | Cell Line, Tumor - drug effects | Gene Expression Profiling | Monocytes - immunology | Membrane Proteins - analysis | Basigin - genetics | Basigin - immunology | Antigens, Neoplasm - analysis | Neoplasm Proteins - genetics | Receptors, Chemokine | Receptors, Cytokine - genetics | Antigens, Neoplasm - immunology | Cell Survival | Adenocarcinoma - immunology | RNA, Messenger - genetics | HLA Antigens - immunology | Pancreatic Neoplasms - ultrastructure | Immunophenotyping | Membrane Proteins - immunology | Cell Membrane - ultrastructure | Neoplasms - ultrastructure | Chemotaxis | Hyaluronan Receptors - genetics | Particle Size | Cell Line, Tumor - ultrastructure | Lung Neoplasms - immunology | Colorectal Neoplasms - immunology | Neoplasms - immunology | Cell Line, Tumor - immunology | Pancreatic Neoplasms - immunology | Colorectal Neoplasms - ultrastructure | Lung Neoplasms - ultrastructure | Neoplasm Proteins - analysis | Receptors, Cytokine - immunology | Cell Membrane - immunology | Genes, MHC Class I | Hyaluronan Receptors - immunology | Apoptosis | Growth factors | Messenger RNA | Tumors | Index Medicus
Journal Article
9.